Results 191 to 200 of about 13,497 (214)
Some of the next articles are maybe not open access.
K-cells and Glucose-Dependent Insulinotropic Polypeptide in Health and Disease
2010In the 1970s, glucose-dependent insulinotropic polypeptide (GIP, formerly gastric inhibitory polypeptide), a 42-amino acid peptide hormone, was discovered through a search for enterogastrones and subsequently identified as an incretin, or an insulinotropic hormone secreted in response to intraluminal nutrients.
Young Min, Cho, Timothy J, Kieffer
openaire +2 more sources
The structure-function relationship of glucose-dependent insulinotropic polypeptide
2009Glucose-dependent insulinotropic polypeptide or gastric inhibitory polypeptide (GIP) is a 42 amino acid endocrine gut hormone which exhibits several direct and indirect effects on fat and glucose metabolism. The first known, and most scrutinized, metabolic function of the hormone was the potentiation of insulin release from pancreatic 13-cells in the ...
openaire +1 more source
Glucose-Dependent Insulinotropic Polypeptide (GIP)
1999M. Michael Wolfe +3 more
openaire +1 more source
Effects of glucose-dependent insulinotropic polypeptide on glucagon
Cardiovascular Endocrinology, 2016Christensen, Mikkel, Knop, Filip K.
openaire +2 more sources
Glucose-Dependent Insulinotropic Polypeptide (GIP)
2004Chi-Chuan Tseng, M. Michael Wolfe
openaire +1 more source
[Clinical significance of glucose-dependent insulinotropic polypeptide (GIP)].
Vnitrni lekarstvi, 1998Findings on the effects of GIP indicate that its incretory effect on stimulation of insulin secretion under conditions of hyperglycaemia is more important than the formerly known effect of enterogastrone. Numerous experimental trials provide evidence that GIP can participate in the regulation of the postprandial glucose and lipid metabolism and ...
openaire +1 more source

